Inhibrx Biosciences (INBX) EBT Margin (2023 - 2025)
Inhibrx Biosciences (INBX) reported EBT Margin of 2204.0% for Q2 2025, down 186021700.0% year-over-year from N/an in Q2 2024, and up 95.4% quarter-over-quarter from 47865.0% in Q4 2024.
Inhibrx Biosciences (INBX) EBT Margin (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of EBT Margin data on file, last reported at 2204.0% in Q2 2025.
- EBT Margin for Q2 2025 came in at 2204.0%, down 186021700.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 10003.79% (down 10201982.0% YoY), and the FY2025 annual result was 10773.31%, down 85456031.0% from the prior year.
- EBT Margin grew to 2204.0% in Q2 2025 per INBX's latest filing, from 47865.0% in the prior quarter.
- Over five years, EBT Margin peaked at 1858013.0% in Q2 2024 and troughed at 156823.33% in Q2 2023.
- A 3-year average of 266995.57% and a median of 24573.63% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin jumped 201483633 bps in 2024, then sank 186021700 bps in 2025.
- A 3-year view of EBT Margin shows it stood at 5628.76% in 2023, then plunged by 750 bps to 47865.0% in 2024, then surged by 95 bps to 2204.0% in 2025.
- Business Quant data shows INBX's EBT Margin at 2204.0% in Q2 2025, 47865.0% in Q4 2024, and 1858013.0% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2,204.00% |
| Dec 31, 2024 | -47,865.00% |
| Jun 30, 2024 | 1,858,013.00% |
| Dec 31, 2023 | -5,628.76% |
| Sep 30, 2023 | -43,518.49% |
| Jun 30, 2023 | -156,823.33% |